Study of a Molecular Promoter for Enhancing Cisplatin Cancer Chemotherapy
Cisplatin is one of the most widely used chemotherapeutic anti-cancer drugs due to its ability to effectively damage DNA and cause cell death. Despite this, cisplatin still suffers from two main drawbacks: toxicity and drug resistance. Many cisplatin-like compounds have been synthesized via traditio...
| Main Author: | |
|---|---|
| Language: | en |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10012/5246 |